Of women with ovarian cancer will survive more than five years from diagnosis
Different subtypes make ovarian cancer a complex disease
More women will face ovarian cancer in our region over the next 25 years.
After six months of symptoms, Karyn received a devastating diagnosis: stage 3C ovarian cancer. Her story is not unique—too many women are diagnosed late, when treatment options are limited, and survival rates remain far too low.
But it doesn’t have to stay this way. With more investment in research, we can catch up to the progress seen in other cancer types and change outcomes for women like Karyn and those to come.
OCRF is driven to accelerate research progress and advocate for better
The experts ensuring we select the most promising projects to fund
Find out which innovative research projects OCRF is supporting
Targeting strategic areas of research to maximise impact on ovarian cancer outcomes
Supporting OCRF means more than funding research—it’s about investing in talented scientists, enabling discoveries, and creating lasting change for all impacted by ovarian cancer.
Together, we can support more ovarian cancer research and drive change.
total funding for research in 2026
awarded in national research grants
projects currently supported nationally
raised in FY 2025
Cutting edge medical research is the key to saving lives and giving hope to women everywhere. Every dollar counts.
Your support enables talented researchers across Australia to find the clues that will make prevention, early detection, and better treatments a reality and change the future for thousands of women and girls.
Host a fundraising event, or make a tax deductible donation to the OCRF today.
Your support enables talented researchers across Australia to find the clues that will make prevention, early detection, and better treatments a reality and change the future for thousands of women and girls.
Together, we can overcome ovarian cancer, but we must act now.



